banner image

健康資訊

 
 
魚油減少關節用藥 Fish oil reduces joint medication

Consuming omega-3 fatty acids as part of the daily diet could reduce the need for painkillers, report researchers at Dundee University. The findings from the study published in the journal Rheumatology, are a welcome revelation, in light of the mounting concerns over the adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs) such as Ibuprofen. Some of these drugs have been associated with gastrointestinal toxicity, high blood pressure and a greater risk of cardiovascular disease.

The double-blind, placebo-controlled study involved 97 RA patients who were given either cod liver oil or a placebo. The researchers found that supplementation with 2.2g long-chain omega-3 fatty acids could result in a reduction in medication by up to 30 per cent after nine months.

An estimated seven million adults in the UK suffer from long-term health problems associated with arthritis, says the Arthritis Research Campaign (www.arc.org.uk), with approximately 350,000 people thought to be suffering from RA – the incurable form of the disease originating in autoimmune problems which bring about painful inflammation in the joints. But there's good news – sufferers may be able to slow the progression of the disease by taking omega-3 supplements. The benefits of these natural anti-inflammatory substances are well documented; earlier studies have suggested that as well as reducing inflammation, certain omega-3 fats actually switch off the collagen-degrading enzymes which break down joint cartilage. Unlike NSAIDs, omega-3 is able to be taken long-term, providing anti-inflammatory and collagen-supporting properties – offering a two-pronged defence against the harmful deterioration of joints affected by RA.

Superior in terms of purity, concentration and efficacy, our pure EPA omega-3 supplements offer significant benefits over the clinical application of cod liver oil. Above all, the removal of DHA ensures that EPA is more bioavailable in the body, promoting the production of anti-inflammatory eicosanoids.